GWD Eradication Status and MDG Absolute Progress Report through 2010.

*<p>Total includes outbreak in Chad (10) and two cases reported by Ethiopia as imported from South Sudan.</p>**<p>South Sudan: Became an independent country in 2011. All GWD cases in 2010 and 2011 were reported in South Sudan.</p>***<p>Absolute Progress is defined by the MDG Report Card as the biggest positive change on the indicators, regardless of their initial conditions.</p

The Millennium Development Goals and Targets.

<p>The Millennium Development Goals and Targets.</p

Prevalence^* of soil-transmitted helminths (STH) and <i>Schistosoma mansoni</i> among children aged 2–15 years.

<p><a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0002223#s3" target="_blank">Results</a> from a cross-sectional survey in South Gondar zone, Amhara Regional State, Ethiopia in 2011.</p>*<p>Estimates weighted according to selection probabilities and adjusted for correlation in the data due to clustering.</p><p>CI, confidence interval.</p

Location of <i>gotts</i> surveyed for both intestinal parasites and trachoma in South Gondar, Amhara Region, Ethiopia in mid-2011.

<p>Location of <i>gotts</i> surveyed for both intestinal parasites and trachoma in South Gondar, Amhara Region, Ethiopia in mid-2011.</p

MF prevalence in 10 sentinel villages: baseline and by year (n = 10,753).

<p>Nocturnal microfilaremia as determined by 60 ul thick smear. The total n value in the table is also reflected in the related graph (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001346#pntd-0001346-g004" target="_blank">Figure 4</a>). Baseline data point is explained in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001346#pntd-0001346-g004" target="_blank">Figure 4</a> legend. NA = not applicable or not available.</p><p>°Started treatment in 2000.</p><p>*Started treatment in 2001.</p><p>**Started treatment in 2002.</p><p>***Started treatment in 2003.</p

Reported village treatment coverage (eligible population): 2004 and 2009.

<p>This x axis shows reported village level treatment coverage ranges based on community CDD registers, and the y axis shows the percent of villages that reported coverages falling into that treatment coverage range for the years 2004 and 2009. Forty-nine percent of 3677 villages reported over 85% coverage of the eligible population in 2006, while 73% of 3638 villages reached that goal in 2009.</p

Mosquito infection rates (all larval stages) in 10 sentinel villages: baseline and by year (n = 44,668).

<p>Dissections from bimonthly intradomiciliary pyrethrum knockdown collections of mosquitoes showing percent infected with any larval stage (L1–3) determined by dissection. Results reflect only <i>Anopheles</i> sp mosquito dissections. Collections were generally performed in the same household compounds. Baseline data point is explained in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001346#pntd-0001346-g006" target="_blank">Figure 6</a> legend. The total n value in the table is also reflected in the related graph (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0001346#pntd-0001346-g006" target="_blank">Figure 6</a>). NA = not applicable, not available, or fewer than 100 mosquitoes dissected.</p><p>°Started treatment in 2000.</p><p>*Started treatment in 2001.</p><p>**Started treatment in 2002.</p><p>***Started treatment in 2003.</p

Mean mosquito infection (all larval stages) by MDA treatment year in 10 sentinel villages (n = 44,668).

<p>Dissections from bimonthly intradomiciliary pyrethrum knockdown collected mosquitos for all larval stages (L1–3) combined across all SVs and adjusted to MDA treatment year for comparability. Baseline mosquito infection rates are the aggregate values from pretreatment and the first two years of treatment; no baseline data were available for Babale SV. Chi square for trend for all years was highly significant (p = 0.008), but the trend analysis was not significant using data between baseline and MDA year 6 (p = 0.131). Bars show 95% confidence intervals.</p

Proportion of households with basic sanitation and access to water in South Gondar, Amhara Region, Ethiopia in three surveys*.

<p>Proportion of households with basic sanitation and access to water in South Gondar, Amhara Region, Ethiopia in three surveys*.</p

Mean sentinel village antigen prevalence by MDA treatment year (n = 9,394).

<p>Filarial antigenemia as determined by ICT testing. SV results across all four MDA phases have been adjusted to MDA treatment year for comparability. Data for the baseline antigen for five villages (Gbuwhen, Gwamlar, Lankan, Maiganga, and Seri) were from 1999–2000 mapping surveys. Baseline for the remaining villages (Akwete, Anzara, Babale, Dokan Tofa, Piapung) combined values from the community wide nocturnal pre-treatment surveys conducted in 2003 with pre-treatment data from the 1999–2000 mapping surveys. Chi square for trend not significant (p = 0.06 for all MDA years and p = 0.271 for baseline through MDA year 6). Bars show 95% confidence intervals.</p